Week in Review | International Myeloma Foundation

doctor prescribing medicine

Week in Review

July 31

June and July 2025: What's New in Myeloma?

microscopic cells byline Dr. Joseph Mikhael

Week in Review

July 24

IMF Chief Medical Officer Dr. Joseph Mikhael Outlines Key Takeaways from ASCO, EHA, and IMWG Annual Meetings for the Myeloma Community

imwg conferences series, week in review blog, part 2

Week in Review

July 3

Top Takeaways from the 2025 IMWG Conference Series: Making Sense of Treatment (Part 2 of 2)

IMWG Conference Series takeaways

Week in Review

July 3

Top Takeaways from the 2025 IMWG Conference Series: Making Sense of Treatment (Part 1 of 2)

teamwork

Week in Review

June 26

May and June 2025: What's New in Myeloma? 

myeloma cells

Week in Review

June 19

The State of Myeloma in 2025

ODAC vote

Week in Review

June 5

A Closer Look at the FDA ODAC Vote Recommending DARZALEX FASPRO® as Treatment for High-Risk Smoldering Myeloma

telehealth communication

Week in Review

May 29

April and May 2025: What's New in Myeloma? 

vial of blood

Week in Review

May 22

Key Points: A Study on the Global and Regional Burden of Myeloma Among Patients Aged 40 and Over

Week in Review

May 15

Q&A with Medical Student Scholar Tyra Grischke and Dr. Ben Derman: On Collaborating and Being Published in Blood Cancer Journal

Drs Joseph Mikhael and Rafat Abonour

Week in Review

May 8

The Future of Myeloma: 'A Fireside Chat' at the Boca Raton Patient & Family Seminar

Sigurdur Ygnvi Kristinsson, MD, PhD, at DeCode Genetics

Week in Review

May 1

A Deep Dive into the IMF’s iStopMM Study

Subscribe to Week in Review

Give Where Most Needed